To assess angiogenesis noninvasively in a C6 rat brain tumor model, the rapid-steady-state-T 1 (RSST 1 ) magnetic resonance imaging (MRI) method was used for microvascular blood volume fraction (BVf) quantification with a novel contrast agent gadolinium per (3,6 anhydro) a-cyclodextrin (Gd-ACX). In brain tissue contralateral to the tumor, equal BVfs were obtained with Gd-ACX and the clinically approved gadoterate meglumine (Gd-DOTA). Contrary to Gd-DOTA, which leaks out of the tumor vasculature, Gd-ACX was shown to remain vascular in the tumor tissue allowing quantification of the tumor BVf. We sought to confirm the obtained tumor BVf using an independent method: instead of using a 'standard' two-dimensional histologic method, we study here how vascular morphometry combined with a stereological technique can be used for three-dimensional assessment of the vascular volume fraction (V V ). The V V is calculated from the vascular diameter and length density. First, the technique is evaluated on simulated data and the healthy rat brain vasculature and is then applied to the same C6 tumor vasculature previously quantified by RSST 1 -MRI with Gd-ACX. The mean perfused V V and the BVf obtained by MRI in tumor regions are practically equal and the technique confirms the spatial heterogeneity revealed by MRI.
Introduction
In neurooncology, it is well established that tumor angiogenesis is correlated with malignancy and clinical outcome. Therefore, objective assessment of tumor angiogenesis can guide the therapeutic strategy and helps in assessing its efficacy.
As malignant tumors are spatially heterogeneous, imaging modalities covering the whole tumor extension are required. Repetitive examinations to study disease evolution or response to treatment require noninvasive methods. Biopsies for histologic analysis neither cover the whole tumor extent nor can they be performed with the frequency of noninvasive imaging.
Magnetic resonance imaging (MRI) methods have been developed that are capable of mapping physiologic markers of angiogenesis qualitatively or quantitatively over a large volume of interest. Blood flow, blood volume fraction (BVf) (Aronen et al, 1994) , vascular permeability (van der Sanden et al, 2000) , and vessel size index (Dennie et al, 1998; Julien et al, 2004) have been used as surrogate markers for tumor angiogenesis and have been found to be related to the tumor grade (Aronen et al, 1994) . Quantitative MRI methods that measure cerebral BVf all require the injection of a blood-pool contrast agent (CA). However, tumor vessels are often abnormally permeable to clinically approved low-molecular CAs. When quantifying the tumor BVf, CA leakage before or during acquisition can result in overstimulation or underestimation, depending on whether the imaging method is based on longitudinal or transverse relaxation, respectively.
We recently developed the rapid-steady-state T 1 (RSST 1 ) method for cerebral BVf mapping (Perles-Barbacaru and Lahrech, 2007) and validated it in healthy rat brain using Gd-DOTA, a clinically approved low-molecular-weight CA (E0.56 kDa), and P760, a macro-molecular (E5.3 kDa) experimental CA from Guerbet (Aulnay-Sous-Bois, France), which are both intravascular in cerebral tissue with an intact bloodbrain barrier. For tumor BVf measurement with the RSST 1 method, we investigated the blood-pool properties of an experimental CA Gd-ACX composed of gadolinium linked to a modified a-cyclodextrin (hexakis(2-O-carboxymethyl-3,6-anhydro)-a-cyclodextrin) in a C6 brain tumor model in rats (Lahrech et al, 2008) . The cerebral BVf measured in brain tissue contralateral to the tumor could be validated by a second measurement in the same animals 1 hour later using Gd-DOTA. Although from the MRI point of view, there is evidence that Gd-ACX remains confined to the vasculature in the C6 tumor model (Lahrech et al, 2008) , we sought to confirm the obtained tumor BVf using an independent method.
Along with autoradiography, histologic assessment of angiogenesis is generally the standard reference method for validating measurements obtained by newly developed methods. Histologic techniques can reveal many morphologic (size, shape, architecture, density) and functional (vascular volume fraction (V V ), permeability) parameters that are often altered in the tumor vasculature. The standard histologic parameter for angiogenesis assessment is microvascular density, but several investigators point out that microvessel density is not a direct correlate of blood volume (Hawighorst et al, 1998) . It does not reflect information about vessel diameter, length, and perfusion status. In particular, tumor vessels are characterized by a large diameter distribution, tortuosity, and incomplete perfusion . In stereology, which provides quantitative three-dimensional (3D) information of objects from measurements on planar sections through them, the vascular area fraction (A A ) is a two-dimensional surrogate of the V V (principle of Delesse). More recently, stereological principles have been used to correct for slice thickness (Pathak et al, 2001 ) and derive a truly 3D vascular V V , which can be better compared with the BVf obtained by MRI. Correlations between such histologic vascular V V and MRI-derived BVf have been found in various studies, but the absolute values are often still different by a factor of two or more (Douma et al, 2010; Valable et al, 2008) .
In this study, the V V is computed from the mean vascular diameter obtained by digital morphometry and the vascular length density (L V ) obtained by a stereological method (Adair et al, 1994) . To make sure we measure two corresponding physical quantities, both BVf and V V were measured in the same animals by MRI and quantitative analysis, respectively. As the percentage of nonfunctional vessels can be relevant in many tumors (Jain, 2001) and the MRI methods based on exogenous CA quantify only circulating blood, a fluorescent dye was injected intravenously to mark the perfused vessels in the histologic sections (van der Sanden et al, 2000) .
The first goal of this study was to investigate the feasibility and limitations of the vascular morphometric analysis on simulated data and on immunohistochemically stained rat vasculature, in particular to show whether vessel diameters can be accurately estimated. The second goal was to compare the BVf obtained by MRI in the C6 tumor model with the obtained histologic parameters (vascular A A and V V ) in the same animals. The results were also compared with published values obtained by alternative techniques for this tumor model.
Materials and methods

Animals
All animal experiments strictly conformed to the Guidelines of the French Government ( 
In Vivo Blood Volume Fraction Measurement: Four
Wistar rats were unilaterally implanted with C6 tumor cells as described in the study by Lahrech et al (2008) .
Three weeks later, in vivo BVf maps were obtained by MRI. Rats (weighing 310 to 400 g) were anesthetized with isoflurane, equipped with a venous and an arterial cannula, thermoregulated, and placed in the prone position for the imaging experiment (Lahrech et al, 2008) .
Ex Vivo Vascular Volume Fraction Measurement:
At the end of the MRI experiment, an intravenous injection of Hoechst 33342 dye (0.2 mL, 6 mg in normal saline solution, Sigma-Aldrich, Saint-Quentin-Fallavier, France), a fluorescent marker for perfused microvessels, was administered. The brains were immediately excised, frozen in liquid nitrogen, and stored at À801C, to stop diffusion of the Hoechst dye into the perivascular tissue.
Tissue Processing: In all, 20 equally spaced coronal sections of 10-mm thickness located within the 2-mm thick MRI slice for BVf mapping were cut on a cryotome HM 560 (Microm International, Walldorf, Germany) at À181C with minimum exposure to white light to avoid degradation of Hoechst fluorescent intensity. The distance from the olfactory bulb on transverse MR images was used to locate the coronal MRI plane through the tumor (expected accuracy within 0.5 mm). One additional section was cut for standard nonspecific histologic analysis of the tumor regions with hematoxylin-eosin staining.
All sections were processed with goat anti-collagen IV (ref 1340-01, Southern Biotechnology Associates., Birmingham, AL, USA) and a second anti-goat antibody labeled with Alexa Fluor 546 (ref A11056, Molecular Probes, Eugene, OR, USA). The staining procedure with the anticollagen IV antibody (diluted 1/100 in phosphate-buffered saline) takes 12 hours in a humid chamber at 41C. Slides are then rinsed in phosphate-buffered saline and exposed for 1 hour at room temperature and in the dark to the secondary antibody conjugated to Alexa 546 (diluted 1/ 100). After a last rinse with phosphate-buffered saline, the slides were refrozen at À901C.
Type IV collagen is a component of the basement membrane, which is present in arterioles, capillaries, and venules and not specific for functional or nonfunctional vessels. The DNA-intercalating Hoechst dye stains the nuclei of endothelial cells in blood vessels, which are perfused at the moment of injection. In tumors, adjacent cells are also stained because the dye has a similar molecular weight (0.56 kDa) as Gd-DOTA and therefore diffuses across a ruptured blood-brain barrier into the tissue.
Image Acquisition
Magnetic Resonance Imaging: Cerebral BVf maps were obtained at a magnetic field strength of 2.35 T in a 40-cm diameter horizontal bore magnet (Bruker Spectrospin, Wissembourg, France). A homogeneous radio frequency (RF) saddle coil was used for emission, and a surface coil for reception. BVf maps were obtained in a coronal plane through the largest extension of the tumor with a spatial resolution of 0.75 Â 0.75 Â 2 mm 3 (Lahrech et al, 2008) using the RSST 1 -MRI method (Perles-Barbacaru and Lahrech, 2007) . During MRI examination, each rat underwent two CA injections: Gd-ACX (administered at a dose of 0.05 mmol/kg in terms of gadolinium) was the CA under investigation and has been found to remain confined to the blood pool even in the tumor tissue, allowing quantification of tumor BVf in this tumor model (Lahrech et al, 2008) . The Gd-DOTA was injected 1 hour later at a dose of 0.1 mmol/kg to show that the tumor vessels were permeable to this low-molecular CA, and to confirm the cerebral BVf in the contralateral tissue having vessels with an intact blood-brain barrier.
Microscopy: The microvasculature was analyzed by epifluorescent microscopy. The tissue sections were scanned using an Olympus DP50 Microscope Digital Camera System (ColorView CCD camera; Olympus, Rungis, France) mounted on a Nikon Microscope Eclipse E600 (Nikon, Champigny Sur Marne, France) and interfaced with digital image processing software (AnalySIS 5.0, Soft Imaging System GmbH, Mü nster, Germany). Two different filter blocks (Nikon) were used for the acquisition of the Hoechst dye (UV-2E/C (DAPI)) and the Alexa Flour 546 dye (G-2E/C ((TRITC)). A composite image (mosaic) was acquired twice, during the same session, at a Â 10 magnification using the DAPI filter first, followed by the TRITC filter. The slides were moved by a high-precision motorized scanning stage controlled by the image processing software. This procedure avoids the necessity of image registration when images have to be matched .
Owing to computer limitations, only a maximum array of 6 Â 6 or 5 Â 7 images could be scanned, representing a total area of 9,146 Â 6,865 mm 2 or 10,664 Â 5,727/7,628 Â 8,002 mm 2 with a pixel size of 0.77 mm. The composite image was computed from individual images using the AnalySIS software. In most cases, this hardly covered the massively enlarged right hemisphere on the coronal slices, almost entirely occupied by the tumor. Little healthyappearing surrounding tissue is included in these images.
The acquisition and image processing time for one composite image was 20 minutes with each filter, i.e., 14 hours for one brain. For this reason, only the tumorbearing hemisphere has been processed.
Image Analysis
Magnetic Resonance Imaging: The BVf maps were computed by averaging over N R = 200 repetitions, according
, where S prei are signals acquired before CA injection and S posti signals acquired within 2.5 minutes after Gd-ACX or Gd-DOTA injection. S 0 is the signal in a protonweighted acquisition (Perles-Barbacaru and Lahrech, 2007) .
Microscopy: Intensities of fluorescent images were analyzed using ImageJ software (National Institute of Health, Bethesda, MD, USA). A custom-made semiautomatic macro was used for image segmentation and feature extraction. A flow chart of the macro is given as Supplementary Material at the JCBFM web site.
Red, green, blue (RGB) images were converted to 8-bit gray-scale images. Regions of interest (ROIs) were defined in the central part (minimum diameter of 1.5 mm) of the tumor and in its periphery (region enhanced by Gd-DOTA minus the central region). As much tumor tissue as possible was included in the ROIs, as had been done when analyzing the MRI data, but when tumor size exceeded the borders of the composite image, the ROIs were smaller than those drawn on MRI-based BVf-maps. Care was taken to exclude large vessels, such as branches of the anterior and middle cerebral arteries.
A plugin for background correction was systematically used. This plugin corrects an uneven image illumination and contrast enhances the resulting image. To avoid user bias, binary masks of the vessels were obtained by thresholding according to the nonparametric approach described by Otsu (1979) where possible, but a manual thresholding was sometimes necessary in tumor ROIs containing very few vessels because of the low contrast and variable background intensity.
After thresholding, profiles composed of at least five adjacent pixels were closed by dilatation, followed by erosion and the vessel lumina were filled in. The binarized image and the original image were compared to verify the binarization process.
Image processing as described above was performed separately on anti-collagen IV-stained images defining the vessel outlines and on Hoechst-stained images carrying information about perfusion status and permeability of the tumor vessels (Figure in Supplementary Material). The final processing step of the Hoechst-stained image was application of a Gaussian blur with s = 10. Binarized Hoechst and anti-collagen IV-stained images were overlaid to select the perfused vessel sections using a Boolean AND operation.
Digital Vascular Morphometry
Particle analysis was carried out using the 'Analyse Particles' and the 'Particles8 Plus' plugins in ImageJ. These plugins derive a number of morphologic parameters for each vessel profile. In addition, ellipses are fitted to each vessel profile, by equalizing the second-order central moments of the ellipse to those of the pixel distribution (Jain, 1989) . For each vessel profile i in an ROI, the following parameters were derived:
A i : the area of the profile (lumen and vessel wall), +IC i : the diameter of the inscribed circle, a i and b i : the major and minor axes of the corresponding ellipse, respectively, the height and width of the bounding box (smallest rectangle that encloses the profile), BDTH i : the breadth which is the widest distance perpendicular to the longest distance (feret) between any two points along the profile boundary (as defined by G Landini in the Particles8 Plus plugin, http://www. dentistry.bham.ac.uk/landinig/software/software.html).
For each ROI j the following parameters were obtained:
A ROIj : the area of the ROI, N j : the number of profiles in the ROI.
From these parameters we calculated:
Nj AROIj , which is commonly considered a measure of the vascular density, A A : the area fraction AA ¼ AROIj, in units of 1/mm 2 , where ai bi is the ratio of the ellipse axes, which is used as a weighting factor based on the assumption that vessels can be approximated as curved and randomly oriented cylinders (Adair et al, 1994) , and V V , the volume fraction
where /dS is the mean vessel diameter.
The mean edge-to-edge vascular diameters including the endothelial wall were estimated by one of the four parameters: diameter of inscribed circle (+IC), minor axis of the ellipse (b), small side of the bounding box (SSBB), and the breadth (BDTH) (cf. Figure 1) . To our knowledge, there is no established morphometric parameter that can be obtained from the two-dimensional shape of vessel crosssections and that reliably represents the vessel diameter, in particular in irregular vessel cross-sections such as occurring in tumor tissue. Therefore, we evaluated the four different parameters (+IC, b, SSBB, and BDTH) for proper estimation of the diameter and the resulting V V using an idealized and a more realistic numeric model of brain vasculature, as well as on plane sections through healthy rat brain vasculature.
Three-Dimensional Numerical Geometric Model
The simulated 512 Â 512 Â 512 voxel binary model (Verant et al, 2007) was composed of a number of straight cylinders with varying diameters and orientations (random distribution with equal probability). The number of cylinders, as well as the minimum and maximum diameter could be chosen to yield the desired total cylinder volume. Three such simulations with different parameters were carried out (cf. Figure 2A ).
Three-Dimensional Numerical Model of the Brain Vasculature
Although the numeric cylinder model was mainly used to determine the most accurate measure of the average diameter, it is a maximally simplified vasculature model. Therefore, we generated a second 512 Â 512 Â 512 voxel numeric model, which reflects the vascular architecture more appropriately (cf. Figure 3A ). Three different models were generated from optic microscopy z-stack acquisitions of the mouse cortical vasculature (Verant et al, 2007) by binarization, closing of the profiles, and increasing the spatial resolution to achieve pixel sizes in the order of 1 mm, comparable to the spatial resolution of the histology sections of the rat cerebral and tumor vasculature analyzed in this study. Although this numeric model accurately reflects the irregular shape, length, and branching of vessels, we have no precise previous knowledge of the average vascular diameter. The two numeric models were also used to determine the minimum number of plane sections required to extrapolate reliable stereological quantities for rather complex structures. Therefore, up to 20 equally spaced entire slices were examined for each of the 3 cylinder models.
Identical image analysis as for the brain slices was performed omitting background correction and thresholding.
For the cylinder and vascular numeric models, the real total volumes V V were determined as the fraction of white voxels over black voxels after analyzing all 512 slices.
Healthy Rat Brain Vasculature
The stereological algorithm and vascular morphometry were also applied to eight anti-collagen IV-stained sections of Wistar rat brains (n = 4). The section thickness was 5 mm and the digitized image had a pixel size of 1.38 mm. Gray matter ROIs in the parietal cortex and in the striatum and a white matter ROI in the corpus callosum were analyzed.
C6 Tumor Vasculature
Vessel analysis as described above was applied on the anti-collagen IV-stained images and then repeated on the selected perfused vessels (Figure in 
Statistical Analysis
Statistical comparisons were performed using GraphPad Prism version 3.02 for Windows (GraphPad Software, San Diego, CA, USA; http://www.graphpad.com). The mean cylinder diameters were compared with the hypothetical mean diameter using a one-sample t-test. The measured vascular parameters were compared using paired t-tests. The significance level was set at 0.05. Values are reported as mean ± one s.d.
Results
Validation Studies
Three-Dimensional Numerical Geometric Model:
The pilot study on the cylinder models showed that the measured or calculated parameters such as L V , P A (number of cylinder profiles per unit area), and mean cylinder diameter reach a constant value with an accuracy within ±5% when the number of test slices used for analysis exceeds B7 or 8. The convergence Figure 2B , the normalized average value is displayed. (C) Difference of the measured volume densities (equation 1) from the real vascular volume density (cf. Figure 2D for details and abbreviations). 3D, three dimensional. is shown in Figure 2B for L V , P A , and the cylinder A A . To compare these parameters for the three different cylinder models, the values are normalized with regard to the average value obtained from all 512 slices. The measured anisotropy L V /P A averaged over the three models was 1.74 ± 0.08.
The bar chart in Figure 2C compares the performance of four different morphologic parameters used to estimate the mean cylinder diameter. All four parameters resulted in mean values that were within the range of cylinder diameters (illustrated by the gray box), but the +IC underestimates the mean cylinder diameter and the SSBB tends to overestimate it. The methods using the b and the BDTH yield cylinder diameters that are not significantly different from the hypothetical mean diameter (18 pixels for the first 2 models and 13 pixels for the third illustrated by the dashed line in Figure 2C ).
Length density correlated well with the number of cylinders in each model. Using the measured length density and the measured mean cylinder diameter, the total cylinder volume was calculated. The relative difference from the given cylinder volume is plotted in Figure 2D . When calculating the cylinder volume from L V using the average b or the average BDTH as an estimate for cylinder diameter, the maximum error was within 16%.
Three-Dimensional Numerical Model of the Brain Vasculature: The same tendencies were found with the vascular geometric model. Figure 3B shows convergence for L V , P A , and the cylinder A A starting at about six slices. Figure 3C shows how the V V is underestimated and overestimated using the +IC and SSBB parameters for diameter estimation, respectively. The V V calculated from the parameter b still tends to underestimate the real V V , with a maximum error of À18% for the vascular geometric models.
From these studies, we conclude that BDTH is the parameter best suited to estimate vessel diameter.
Healthy Rat Brain Vasculature: Table 1 shows that the diameters of the healthy rat brain vasculature estimated by BDTH are in the range of those reported in the literature: 7 to 8 mm (Deane and Lantos, 1981; Pathak et al, 2001) . No significant regional differences in this parameter were found in accordance with the literature (Schlageter et al, 1999; Weiss et al, 1982) .
The vascular A A (a measure independent of the estimation of the vessel diameters) yielded a significantly lower value. For in vivo studies, the results obtained with +IC, b, and SSBB are omitted because for these parameters the same tendencies as for the numerical geometric models were observed yielding even unphysiologically small and large vessel diameters for +IC and SSBB, respectively. Table 1 also shows the vascular P A and L V , both being highest in the cortex and lowest in the corpus callosum in accordance with the literature.
C6 Tumor Vasculature
Microscopy: Histologic examination of the hematoxylin-eosin-stained C6 tumor-bearing sections revealed large areas of necrosis, predominantly in the central part of the tumor, containing very few and deformed vessels, cystic formations, and a narrow band of viable pleomorphic proliferating cells in the tumor periphery. In some animals, the histologically defined tumor size exceeded the one deduced from T 2 -weighted and contrast-enhanced T 1 -weighted images.
Magnetic Resonance Imaging: This study was carried out on very large advanced-stage tumors: in the slice used for BVf mapping by MRI, the area of contrast enhancement after Gd-DOTA injection covered B50% of the whole brain section (Lahrech et al, 2008) and a substantial shift of the median line was observed in all brains.
The PaCO 2 in tumor-bearing rats measured before both CA administrations was slightly higher (mean of 47.0±6.8 mm Hg) than usually observed in healthy rats under these experimental conditions. Magnetic resonance imaging-derived BVfs averaged for all eight tumor-bearing rats were (Lahrech et al, 2008 ): 1.32% ± 0.40% in the tumor periphery, 0.34% ± 0.28% in the tumor center, and 0.94%±0.16% in the contralateral hemisphere.
The BVf obtained by MRI in the four animals that underwent vascular morphometry was 1.38% ± 0.46% in the tumor periphery and 0.46%±0.29% in the tumor center. In the contralateral hemisphere, similar BVf values were obtained with both CA: 1.02%±0.25% and 1.09%±0.33% with Gd-ACX and Gd-DOTA, respectively. In Figure 4 , images of a representative tumor-bearing rat brain are shown. The area enhanced by Gd-DOTA on the T 1 -weighted Figure 4A ) is outlined. The corresponding BVf map is given in Figure 4B together with a corresponding histologic Hoechst-stained image covering a large part of the tumor ( Figure 4C ). This advanced-stage C6 tumor model is characterized by a high BVf heterogeneity. The BVf map exhibits low blood volume in the center of the tumor ROI ( Figure 4B ) and some areas characterized by a higher blood volume in the periphery. Hoechst staining confirms a low vessel density in this ROI ( Figure 4C ). Only few vessels that are highly permeable to the Hoechst dye are visible. Interestingly, in this example, vasculature permeable to the Hoechst dye was observed well beyond the region enhanced by Gd-DOTA, showing that the tumor extent might be misinterpreted using contrast-enhanced MRI only. Figure 5 shows overlays of Hoechst-and collagen IV-stained microvasculature in the periphery ( Figure 5A ) and in the center ( Figure 5B ) of a C6 glioma showing extravasation of the Hoechst dye with diffusion into the perivascular tissue. Figure 5C corresponds to the view in Figure 5B and illustrates the segmented vessels with the perfused vessels in red and the nonperfused vessels in gray. Figure 5 also shows the collagen IV-stained microvasculature in healthy cortical gray matter ( Figure 5D ) and in healthy callosal white matter ( Figure 5E ) for comparison. No Hoechst extravasation was observed in the contralateral brain tissue.
The bar charts in Figures 6A and 6B compare the V V obtained by vascular morphometry using BDTH to estimate the mean vessel diameter and the vascular A A with the BVf obtained by MRI with Gd-ACX as blood-pool CA.
Compared with the perfused vasculature ( Figure 6A) , V V and A A of all vessels ( Figure 6B) were by a factor of B2 and 2.6 greater, respectively. As shown in Figure  6C , this is rather attributed to a smaller diameter of the perfused vessels than to a partial perfusion (reflected by a slightly decreased vascular P A ).
Discussion
To date, MRI is the only noninvasive brain imaging method that can measure the BVf regionally regardless of the tumor location and depth, but blood-pool CAs are required for quantification. In malignant brain tumors, the vascular endothelium is often permeable to low-molecular-weight CAs, such as Gd-DOTA, precluding BVf quantification. In our previous study (Lahrech et al, 2008) , we used the RSST 1 technique (Perles-Barbacaru and Lahrech, 2007) with Gd-ACX, providing evidence for the vascular confinement of this new CA in a C6 rat brain tumor model enabling the quantification of the tumor BVf. In this study, we measured the tumor BVf in the same animals by MRI with Gd-ACX and by vascular morphometric analysis combined with a stereological technique.
The stereological technique derives the V V from the mean vessel diameter (power of two!; cf. equation 1) and is therefore very sensitive to the correct estimation of this parameter. Consequently, the first aim of this study was to establish the most appropriate measure of vessel diameter. This validation study was necessary because there is no consensus on which is the best measure for the 'diameter' of an irregularly shaped profile. It was carried out on 3D numerical models of straight cylinders and cortical vasculature, as well as on histology sections of the rat brain vasculature. Although in the cylinder model, all four studied morphologic parameters used for diameter estimation yielded results within the given range of cylinder diameters, the four morphologic parameters yielded fairly different results for the more irregularly shaped vascular profiles in the brain tissue. Our studies on the numerical geometric models show that when using b or BDTH as diameter, the estimation of the total V V is accurate within 18%. The mean vessel diameters in the rat brain obtained showing a few enlarged vessels in the tumor periphery and sparse-perfused and Hoechst-permeable vessels in the tumor center. Such vessels are also observed beyond the tumor outline deduced from Gd-DOTA signal enhancement. In this particular case, acquisition of the fluorescent image does not cover the dorsal part of the tumor. BVf, blood volume fraction; MRI, magnetic resonance imaging; RSST 1 -MRI, rapid-steady-state-T 1 -MRI.
from BDTH are in accordance with the literature (Deane and Lantos, 1981; Farrell et al, 1991; Pathak et al, 2001; Schlageter et al, 1999) . However, because determination of the diameter is method dependent, it is difficult to compare vessel diameters measured by different investigators. In addition, some authors average the vessel diameters only over a particular range, defining, e.g., the microvasculature as vessels with diameters < 12 mm (Weiss et al, 1982) . The vascular A A , a two-dimensional surrogate for the vascular V V or BVf, although more sensitive to the Holmes effect (projected size of the object greater than or equal to real size (Hennig, 1969) ), is independent of the estimation of the vessel diameters, and yields values in the order of the stereologically obtained V V , supporting the stereological technique.
Vascular V V values obtained in healthy rat brain tissue in our study are in the range of published values (Table 2) . Morphometric methods generally report vascular V V or A A between 1% and 2% (Dunn et al, 2004; Pathak et al, 2001 Pathak et al, , 2003 , although some authors found values up to 3% (Schlageter et al, 1999) or 5% (Weiss et al, 1982) , depending on the stereological technique used. There also is evidence that not all vessels are perfused in the healthy brain tissue (Shockley and LaManna, 1988; Weiss et al, 1982) . However, the major methodological impact on cerebral BVf measurement seems to originate from whether the BVf is measured in vivo or post mortem. From Table 2 , it can be seen that with few exceptions, in vivo BVf measurements yield values in the range of 2% to 4%, whereas lower BVf values were reported in postmortem studies (Bereczki et al, 1992) .
Comparing in vivo MRI with an invasive method such as histology is technically challenging because the data (the brain sections) are not in the same format and have different spatial resolutions. Each technique has additional limitations.
Although we took care to define similar ROIs on the MRI and histologic slices when possible, the nonparametric correlation between MRI BVf and stereological vascular V V in the tumor tissue was not statistically significant (r S = 0.32). It is generally easier to show a correlation between two techniques when data from a healthy brain are used, rather than data from heterogeneous tumor tissues (Pathak et al, 2001) . Although Pathak et al found a significant correlation between morphologic estimates and MRIbased BVf in healthy tissues, the correlation was poor for the tumor microvasculature. Unfortunately, contralateral vascular V V for correlation with MRI data was not available in this experiment. Recent studies carried out in the laboratory (Valable et al, 2008) compare the BVf obtained in a C6 rat brain tumor model by the steady-state DR 2 * method using a superparamagnetic CA with the vascular V V computed according to Pathak's stereological method for slice thickness correction (Pathak et al, 2001) . Although only anti-collagen IV staining was used for microvessel delineation in this study, a significant correlation was observed between the histologic and MRI data, but the histologic vascular V V was only about one-third of the BVf measured by MRI. For the C6 tumor tissue in our study, there was a good numerical agreement between the BVf measured by RSST 1 -MRI and vascular V V obtained by the stereological technique. This might be attributed to the lower slice thickness or the high number of slices used in our study.
Blood water detected by the RSST 1 technique or any other MRI technique using CAs for BVf measurement is the one contained in perfused vessels. Our results confirm that, when comparing the BVf measured by MRI in certain tumors with a histologic technique, care should be taken to restrict vascular analysis to perfused vessels. Numerous tumor specific features, such as irregular vessel architecture, abnormal vascular barrier, and elevated interstitial fluid pressure, result in reduced blood flow in parts of the tumor (Jain, 1988) .
The size difference between perfused and unperfused vessels might be explained by vessel compression outside the plane leading to stasis and enlarged vessels. The diameter of the perfused vessels may also be decreased in the postmortem study owing to vessel collapse. The mean diameters of the tumor vessel profiles were in accordance with published values for the C6 tumor model (Farrell et al, 1991; Tropres et al, 2004) . In our study, the diameters of perfused tumor vessels were not significantly different from those in the healthy rat brain, although enlarged tumor vessels with regard to the contralateral cortical tissue were observed in some other studies carried out on the C6 tumor model (Dennie et al, 1998; Tropres et al, 2004) . As reported in the study by Lahrech et al (2008) , the vasculature in brain tissue contralateral to the tumor might not be representative of the healthy brain vasculature owing to compression, edema, or inflammation caused by the tumor and affecting the vessel size. As shown in our study, another potential reason for this discrepancy might be that the 'diameter' of irregular vessel cross-sections depends very much on Figure 6 Comparison between stereologically obtained vascular volume fractions and blood volume fractions obtained by MRI. (A and B) The V V calculated from BDTH, as well as the A A for perfused vessels (anti-collagen IV staining + Hoechst overlay) only (panel A) and for all anti-collagen IV-stained vessels (panel B) are compared with the BVf measured by MRI with Gd-ACX in the C6 tumor periphery and center. The volume fractions obtained by vascular morphometry for the perfused vasculature are not statistically different from the BVf obtained by MRI, whereas using anti-collagen IV staining alone leads to an overestimation. (C) Comparison of vascular parameters obtained from all microvessels and perfused microvessels in C6 tumor regions. The vascular V V is not only determined by the vascular density reflected by the P A but in particular also by the vessel diameter. V V = volume fraction, A A = area fraction, BVf = blood volume fraction, b = minor axis of ellipse, BDTH = breadth, P A = profiles per unit area. MRI, magnetic resonance imaging. *Significantly (0.05) different.
the morphologic parameter used. For example, Tropres et al (2004) (p. 536 to 537) calculated for every intravascular pixel the shortest distance to the vessel wall and used the greatest value among all intravascular pixels as an estimate for the vessel diameter. Although in almost elliptical cross-sections, this parameter would result in the same measure as the breadth, it is likely that it differs from the breadth in irregular vessel cross-sections. In addition, when reporting the average vessel diameter in tumors, these authors also included nonfunctional vessels.
The ratio of perfused V v to total V v was B0.4 to 0.6 in this late-stage glioma model. This is in accordance with observations made by Bernsen et al (1995) who found that the perfused (area) fraction of tumor vessels ranged from 0.20 to 0.85 in subcutaneous tumors in mice. The perfusion fraction was in the same range or significantly lower in intracerebrally implanted human glioma xenografts in nude rats (Bernsen et al, 1999) .
Owing to the characteristics and combined limits of the immunohistological, digital vascular morphometry, and stereological techniques, including image quality, thresholding, choice of morphometric parameters, etc., the vascular V V evaluated in this study is only an estimation and no uncertainty interval can be given. Uncertainties also exist with the MRI technique: Although with the RSST 1 -MRI technique only the intravascular water should contribute to the signal, the water exchange (Perles-Barbacaru and Lahrech, 2007) probably extends the origin of the acquired signal to the vessel wall or beyond.
Nevertheless, the stereological estimation of V V of the perfused tumor vasculature is similar to BVf obtained by MRI supporting the vascular confinement of the CA Gd-ACX, despite the presence of the vascular endothelium permeable to Gd-DOTA. (2005) CBV, cerebral blood volume; MV, macroscopic vessels; ROI, region of interest; SSDR 2 *ÀMRI, steady-state DR 2 * magnetic resonance imaging; SST 1 ÀMRI, steady-state T 1 -weighted magnetic resonance imaging; SRQCT, synchrotron radiation quantitative computed tomography; 3D, three dimensional. Reported values for the regional cerebral blood volume obtained using various imaging techniques. Decimal places and s.d. are given as reported in the original study. a Rats anesthetized with halothane. b14 C-dextran labeled plasma and 99m Tc-labeled red blood cells. 
Conclusions
There is no real gold standard for quantifying the BVf by histologic vascular analysis. Here, a robust technique for vascular volume fraction measurement is proposed, which requires the measurement of the vascular diameters. There is no gold standard for measuring the vascular diameters neither. In this study, we therefore compare the vascular diameters obtained in four different ways and we conclude that the BDTH is the most appropriate parameter. This conclusion is based on the criterion that the estimated diameters are in accordance with the literature and that resulting vascular volume densities correlate best with the vascular area fraction, which is a generally accepted histologic surrogate for BVf measurement. The vascular volume fraction obtained by quantitative vascular morphometry combined with a stereological algorithm was compared with the tumor blood volume measured using the quantitative RSST 1 -MRI method in conjunction with Gd-ACX, a new CA with blood-pool properties in the tumor vasculature. Despite some uncertainties regarding the morphometric analysis, an almost quantitative equivalence could be established for the tumor blood volume between the two independent techniques. The fact that the in vivo BVf measured by MRI is not significantly greater than the vascular V V , confirms that Gd-ACX remains confined to the blood pool even in the vasculature of this advanced-stage C6 tumor that is mostly permeable to Gd-DOTA. The BVf measurement using a blood-pool CA such as Gd-ACX is therefore reliable and noninvasive and suitable for angiogenesis assessment.
Morphometric analyses also revealed one of the reasons for the low tumor blood volume, which is that the perfused vasculature makes up only half of the total vascular volume fraction. This partial perfusion is much less apparent when only vascular density is considered.
